Chicago Center for Clinical Research

Chicago, Illinois 606104234

0 studies enrolling now · 3 studies all time

What they study most

Alzheimer Disease

Studies at this site

• The Safety and Efficacy of an Investigational Drug in Delaying the Progression of Alzheimer's Disease — Stopped early
• 18-Month Study of the Efficacy of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type — Completed
• Evaluation of Galantamine in the Treatment of Alzheimer's Disease — Completed